Cargando…

New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell

BACKGROUND: Solid lipid nanoparticles (SLNs) are colloidal carrier systems which provide controlled-release profiles for many substances. In this study, we prepared aqueous dispersions of lipid nanoparticles using a modified, pH-sensitive derivative of phosphatidylethanolamine. METHODS: SLNs were pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashanian, Soheila, Azandaryani, Abbas Hemati, Derakhshandeh, Katayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218572/
https://www.ncbi.nlm.nih.gov/pubmed/22114489
http://dx.doi.org/10.2147/IJN.S20849
_version_ 1782216698741391360
author Kashanian, Soheila
Azandaryani, Abbas Hemati
Derakhshandeh, Katayoun
author_facet Kashanian, Soheila
Azandaryani, Abbas Hemati
Derakhshandeh, Katayoun
author_sort Kashanian, Soheila
collection PubMed
description BACKGROUND: Solid lipid nanoparticles (SLNs) are colloidal carrier systems which provide controlled-release profiles for many substances. In this study, we prepared aqueous dispersions of lipid nanoparticles using a modified, pH-sensitive derivative of phosphatidylethanolamine. METHODS: SLNs were prepared using polysorbate 80 as the surfactant and tripalmitin glyceride and N-glutaryl phosphatidylethanolamine as the lipid components. Particle size, polydispersity index, and zeta potential were examined by photon correlation spectroscopy. Morphological evaluation was performed using scanning electron microscopy, atomic force microscopy, and differential scanning calorimetry. RESULTS: Photon correlation spectroscopy revealed a particle hydrodynamic diameter of 165.8 nm and zeta potential of −41.6.0 mV for the drug-loaded nanoparticles. Atomic force microscopy investigation showed the nanoparticles to be 50–600 nm in length and 66.5 nm in height. Differential scanning calorimetry indicated that the majority of SLNs possessed less ordered arrangements of crystals compared with corresponding bulk lipids, which is favorable for improving drug-loading capacity. Drug-loading capacity and drug entrapment efficiency values for the SLNs were 25.32% and 94.32%, respectively. CONCLUSION: The SLNs prepared in this study were able to control the release of triamcinolone acetonide under acidic conditions.
format Online
Article
Text
id pubmed-3218572
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32185722011-11-23 New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell Kashanian, Soheila Azandaryani, Abbas Hemati Derakhshandeh, Katayoun Int J Nanomedicine Original Research BACKGROUND: Solid lipid nanoparticles (SLNs) are colloidal carrier systems which provide controlled-release profiles for many substances. In this study, we prepared aqueous dispersions of lipid nanoparticles using a modified, pH-sensitive derivative of phosphatidylethanolamine. METHODS: SLNs were prepared using polysorbate 80 as the surfactant and tripalmitin glyceride and N-glutaryl phosphatidylethanolamine as the lipid components. Particle size, polydispersity index, and zeta potential were examined by photon correlation spectroscopy. Morphological evaluation was performed using scanning electron microscopy, atomic force microscopy, and differential scanning calorimetry. RESULTS: Photon correlation spectroscopy revealed a particle hydrodynamic diameter of 165.8 nm and zeta potential of −41.6.0 mV for the drug-loaded nanoparticles. Atomic force microscopy investigation showed the nanoparticles to be 50–600 nm in length and 66.5 nm in height. Differential scanning calorimetry indicated that the majority of SLNs possessed less ordered arrangements of crystals compared with corresponding bulk lipids, which is favorable for improving drug-loading capacity. Drug-loading capacity and drug entrapment efficiency values for the SLNs were 25.32% and 94.32%, respectively. CONCLUSION: The SLNs prepared in this study were able to control the release of triamcinolone acetonide under acidic conditions. Dove Medical Press 2011 2011-11-01 /pmc/articles/PMC3218572/ /pubmed/22114489 http://dx.doi.org/10.2147/IJN.S20849 Text en © 2011 Kashanian et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Kashanian, Soheila
Azandaryani, Abbas Hemati
Derakhshandeh, Katayoun
New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title_full New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title_fullStr New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title_full_unstemmed New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title_short New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell
title_sort new surface-modified solid lipid nanoparticles using n-glutaryl phosphatidylethanolamine as the outer shell
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218572/
https://www.ncbi.nlm.nih.gov/pubmed/22114489
http://dx.doi.org/10.2147/IJN.S20849
work_keys_str_mv AT kashaniansoheila newsurfacemodifiedsolidlipidnanoparticlesusingnglutarylphosphatidylethanolamineastheoutershell
AT azandaryaniabbashemati newsurfacemodifiedsolidlipidnanoparticlesusingnglutarylphosphatidylethanolamineastheoutershell
AT derakhshandehkatayoun newsurfacemodifiedsolidlipidnanoparticlesusingnglutarylphosphatidylethanolamineastheoutershell